Canine Enteropathy: Food, Antibiotic, and Steroid Responsive Subtypes

Last updated: May 23, 2026

Why the WSAVA Framework Matters

The old umbrella term “inflammatory bowel disease” lumped together every dog with chronic GI signs and a biopsy showing inflammation, then treated them all with steroids. The modern WSAVA framework — championed by the World Small Animal Veterinary Association GI standardization group — replaced that mess with a tidy treatment-response classification. A canine responsive enteropathy is named after what makes it better.

The three subtypes are food-responsive enteropathy (FRE), antibiotic-responsive enteropathy (ARE, also called antibiotic-responsive diarrhea or dysbiosis), and steroid-responsive enteropathy (SRE, the old “IBD” group). Dogs are walked through the categories in sequence — cheapest and lowest-risk trial first, immunosuppression last. The result: most dogs respond to FRE or ARE and never need lifelong immunosuppressive medications.

For the symptom-and-pathology overview, see chronic enteropathy in dogs. This guide focuses on the decision framework that determines which subtype a dog ends up in.

What Counts as Chronic Enteropathy?

Chronic enteropathy means GI signs — vomiting, diarrhea, weight loss, hyporexia, or any combination — lasting 3 or more weeks with infectious, parasitic, dietary indiscretion, and obstructive causes excluded. The minimum workup before entering the FRE/ARE/SRE framework includes:

• Fecal centrifugation and giardia testing (with empirical fenbendazole if any doubt)
• CBC, chemistry panel, urinalysis
• Resting cortisol or ACTH stimulation to exclude atypical Addison’s, which classically masquerades as chronic GI disease
• Pancreatic lipase (Spec cPL) to exclude chronic pancreatitis
• Cobalamin (B12) and folate to flag small bowel disease
• Trypsin-like immunoreactivity (TLI) if exocrine pancreatic insufficiency is on the differential
• Abdominal ultrasound to rule out mass, foreign body, intussusception

Only after this rule-out passes do you start the responsive-enteropathy trials. Skipping these steps gets dogs labeled FRE-failure when they actually have an untreated parasitic infection or Addison’s disease.

Step 1: Food-Responsive Enteropathy Trial

FRE is the single most common chronic enteropathy in dogs — somewhere between 50 and 70 percent of cases by most published series. It is also the cheapest and lowest-risk to diagnose, which is why the WSAVA framework starts here.

The trial: 8 weeks of a single therapeutic diet, no treats, no flavored medications, no human food, no chews, no dental products with flavor. The diet should be either a veterinary hydrolyzed protein product (Royal Canin Hydrolyzed Protein, Hill’s z/d, Purina HA) or a true novel-protein diet using a protein source the dog has never eaten. Most over-the-counter “limited ingredient” foods do not meet the standard because of cross-contamination.

Improvement is often dramatic and fast — many FRE dogs are clinically better within 2 to 3 weeks. The 8-week endpoint exists to be sure the response is real and not coincidental. After the trial, optional rechallenge with the original food confirms FRE if signs recur. Many owners skip the rechallenge and keep the dog on the therapeutic diet indefinitely.

For broader food-transition strategy, see how to switch dog food. For owners of dogs whose diarrhea responds to dietary change but other workup steps remain pending, the dog diarrhea causes reference is the cousin overview.

Step 2: Antibiotic-Responsive Enteropathy Trial

If 8 weeks of strict diet trial does not produce meaningful improvement, the next step is an antibiotic trial. ARE is associated with small intestinal dysbiosis — an unfavorable shift in microbiome composition that responds to antimicrobial intervention. Young large-breed dogs (German Shepherds especially) are over-represented.

Tylosin (typically 5 to 15 mg/kg PO q12h) and metronidazole (10 to 15 mg/kg PO q12h) are the historical first choices. A trial runs 4 to 6 weeks; responders often relapse when the antibiotic stops, requiring either intermittent re-dosing or transition to dietary fiber and prebiotic strategies for long-term control.

Caution with metronidazole has grown: recent evidence shows it disrupts the microbiome for weeks to months after a course ends, and chronic use is not as benign as once thought. Many internists now prefer tylosin or rifaximin (where available) and reserve metronidazole for short courses or specific indications.

An ACVIM-Nutrition referral helps for dogs with concurrent malabsorption and weight loss who are entering long-term dietary management. The combined diet-plus-low-dose-tylosin approach often holds dogs in remission longer than either alone.

Step 3: Steroid-Responsive Enteropathy (and Immunosuppression)

Dogs who fail both diet and antibiotic trials get GI biopsies (endoscopic upper and lower if signs are mid-gut; full-thickness surgical if there is concern for lymphoma or transmural disease). Histology guides therapy. Most SRE dogs have lymphoplasmacytic or eosinophilic infiltrates without overt lymphoma.

Treatment starts with prednisone or prednisolone at an immunosuppressive dose, tapered over months to the lowest effective dose. Budesonide is an alternative for dogs with steroid-side-effect intolerance because of high first-pass hepatic metabolism. Cyclosporine, chlorambucil, or mycophenolate are second-line agents for steroid-refractory cases or steroid-sparing in dogs who cannot tolerate prednisone long-term.

The chronic enteropathy clinical activity index (CCECAI) and serum cobalamin are the standard monitoring tools. Cobalamin deficiency is common in distal small bowel disease and requires parenteral (or high-dose oral) supplementation — improvement on cobalamin alone can be substantial in some patients.

Prognosis on the SRE pathway is more variable than FRE or ARE. Most dogs achieve a quality remission; a meaningful minority remain difficult to control. Lymphoma sometimes hides behind a steroid-refractory enteropathy diagnosis and emerges on repeat biopsy.

Concurrent Issues to Watch

Pancreatitis frequently coexists with chronic enteropathy. Any dog on the responsive-enteropathy pathway with persistent vomiting or abdominal pain deserves a Spec cPL recheck and consideration of a low-fat diet trial — see our canine pancreatitis recovery and dietary management guide and dog pancreatitis diet reference.

Protein-losing enteropathy (PLE) is the severe end of SRE — a dog with hypoalbuminemia, edema, or ascites is in a different prognostic category and needs aggressive workup including consideration of intestinal lymphangiectasia. Yorkshire Terriers, Soft-Coated Wheaten Terriers, and Norwegian Lundehunds are predisposed.

Coprophagia in an underweight, chronically GI-sick dog is a clinical clue, not a behavioral quirk. The dog coprophagia management guide walks through the medical rule-outs that often hit the same enteropathy patient population.

Living With a Responsive-Enteropathy Dog

Long-term, most FRE dogs eat their therapeutic diet for life and live entirely normal lives. ARE dogs cycle through occasional flares with intermittent antibiotic or prebiotic intervention. SRE dogs require lifelong monitoring with periodic albumin, B12, and body weight checks. Owners benefit from a flare-plan: which signs trigger a vet call, which trigger an at-home dietary tighten-up, and which trigger nothing.

The single most owner-driven failure mode is treat creep — a chunk of cheese here, a flavored chew there. For FRE dogs, this undoes weeks of trial work. Build a “permitted treats” list with your veterinarian and stick to it.

The Breed-Specific Patterns

Some breeds map predictably onto specific enteropathy subtypes. German Shepherds are over-represented for both ARE (small intestinal dysbiosis is documented in the breed) and for exocrine pancreatic insufficiency, which complicates the picture because EPI dogs cannot be evaluated for ARE until the pancreatic enzyme deficiency is replaced. Always run a TLI in a German Shepherd with chronic GI signs before starting the FRE/ARE/SRE pathway.

Yorkshire Terriers and Soft-Coated Wheaten Terriers are predisposed to protein-losing enteropathy with intestinal lymphangiectasia. Affected dogs present with hypoalbuminemia, sometimes ascites or limb edema, and progressively worsening signs. Treatment is more aggressive and uses ultra-low-fat diet (under 5 percent ME from fat in some cases) combined with immunosuppression.

Boxers, Bulldogs, and a few other breeds develop a specific granulomatous colitis that historically was misclassified as IBD and treated unsuccessfully with steroids for years. The actual cause is an invasive E. coli infection inside colonic macrophages, and the treatment is a prolonged course of enrofloxacin. Boxers with chronic large-bowel diarrhea — straining, frequency, mucus, blood — should get fluorescent in situ hybridization (FISH) on a colonic biopsy to confirm the diagnosis before being labeled refractory SRE.

Concurrent Stool Eating and Behavioral Signs

Many chronic enteropathy dogs eat stool, others, or themselves. Owners often see the behavior before they see the GI illness because the abnormal eating is the first noticeable thing. A thin, chronically GI-sick dog who has just started coprophagia is not behavioral — they are calorie-starved. Putting them through the full medical rule-out before behavioral training is the right sequence.

Other behavioral signs to watch for include slow chewing, repeated swallowing motions (reflux), licking surfaces compulsively (often a sign of nausea), and intermittent food refusal that the owner attributes to “pickiness.” Resolution of these behavioral signs with successful enteropathy management is common and tells you the diagnosis is correct.

The Cost Picture and Adoption Realities

FRE management has reasonable lifetime costs — a prescription hydrolyzed diet runs more than standard kibble but is the only major recurring expense for most dogs. ARE adds intermittent antibiotic costs. SRE is the most expensive subtype because of medication costs (cyclosporine, chlorambucil), routine monitoring bloodwork, and potential specialist visits.

For adopters considering a dog with documented chronic enteropathy, the FRE or ARE dog is an entirely manageable adoption. SRE dogs in stable remission are also manageable but warrant honest discussion of recheck cadence and potential flare costs. Bringing the previous biopsy report, current medications list, and recent bloodwork to the first new-vet visit avoids redundant workup.

Frequently Asked Questions

How strict is the 8-week diet trial really?

Completely strict. One pill pocket, one flavored heartworm chew, or one slip of human food can confound the trial. If owners cannot commit to absolute strictness, the trial cannot be interpreted and treatment ends up cycling through unnecessary steroids.

Can I use an over-the-counter limited-ingredient diet instead of a prescription one?

Generally no. Cross-contamination in pet food manufacturing facilities is well-documented, and a true elimination trial needs a veterinary hydrolyzed or carefully sourced novel protein. The economics favor the trial diet over months of failed workup.

Is metronidazole safe for chronic use?

Less so than was previously assumed. Modern evidence supports short courses for specific indications rather than open-ended use. Tylosin is generally preferred for ARE trials, and any chronic antibiotic strategy deserves regular reassessment with an internist.

Will my dog need steroids forever?

Most FRE and ARE dogs never need steroids. SRE dogs typically taper to the lowest effective dose, which is sometimes very low and sometimes requires steroid-sparing immunosuppression. Lifelong moderate-dose steroid is uncommon with modern management.

When do I push for biopsy versus another diet?

If 8 weeks of true hydrolyzed diet trial plus 4 to 6 weeks of antibiotic trial have failed, biopsy is the next step. Cycling through more diets without histology delays definitive therapy and wastes months in a thin, sick dog.